NO of isolates and DANO MIC (μg/mL)
|
Topoisomerases and gyrase mutations
|
Efflux-related mutations
|
---|
gyrA
|
parC
|
parE
|
marR
|
acrR
|
---|
13 (128); 2 (64);
|
S83L, D87N
|
None
|
None
|
None
|
None
|
2 (128); 1 (64)
|
S83L, D87N
|
S80I
|
None
|
None
|
None
|
5 (128); 3 (64)
|
S83L, D87N
|
S80I
|
None
|
G103S
|
None
|
2 (128); 1 (32)
|
S83L, D87N
|
None
|
None
|
G103S
|
None
|
2 (128); 1 (32); 2 (8)
|
None
|
S80I
|
None
|
G103S
|
None
|
1 (128); 1 (64)
|
S83L, D87N
|
S80I
|
I355T,L416F
|
None
|
None
|
1 (128)
|
None
|
S80I
|
None
|
G103S
|
V29G
|
1 (64)
|
S83L, D87Y
|
S80I
|
None
|
G103S
|
None
|
1 (64)
|
S83L, D87H
|
None
|
None
|
G103S
|
None
|
1 (64)
|
S83L, D87N
|
None
|
None
|
D67N,G103S
|
None
|
1 (32)
|
S83L, D87Y
|
S80I
|
None
|
None
|
None
|
2 (32)
|
S83L
|
None
|
None
|
G103S
|
None
|
1 (32)
|
S83L
|
None
|
None
|
None
|
None
|
1 (32)
|
S83L, D87G
|
None
|
None
|
None
|
None
|
1 (16)
|
None
|
S80I, E84K
|
None
|
None
|
None
|
1 (16)
|
None
|
E84K
|
None
|
None
|
None
|
1 (1)
|
None
|
S80I
|
None
|
None
|
None
|
1 (32)1 (4); 1 (1)
|
None
|
None
|
None
|
G103S
|
None
|
mutation rate
|
52.70%
|
28.38%
|
2.70%
|
35.14%
|
1.35%
|
- Note: DANO Danofloxacin, NO number